Skip to content

Bond™ PA0009

by Leica Biosystems Newcastle, Limited

Ref PA0009

Bond PA0009 is an in vitro diagnostic device (EU IVDD general IVD; FDA Class II; FDA product code MYA, Immunohistochemistry Antibody Assay, Estrogen Receptor) made by Leica Biosystems Newcastle, Limited, registered in EUDAMED on 4 Jun 2026 (Basic UDI-DI B-05055331320421) and listed in FDA GUDID since 24 Sep 2016 (UDI-DI 05055331320421), active as of 22 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-05055331320421 Basic UDI-DI 05055331320421UDI-DIDate4 Jun 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number05055331320421 UDI-DI Date24 Sep 2016ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Estrogen Receptor Clone 6F11 (ER 6F11) Mouse Monoclonal antibody is intended for laboratory use to qualitatively identify estrogen receptor (ER) antigen in sections of formalin fixed, paraffin embedded breast cancer tissue by immunohistochemistry methods.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-05055331320421 registered 4 Jun 2026 Active
  • FDA GUDID UDI-DI 05055331320421 listed 24 Sep 2016 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 05055331320421
  2. Registered EUDAMED B-05055331320421

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Estrogen Receptor 6F11 30 mL EUDAMED
Bond™ GUDID
Generic name
Estrogen (oestrogen)/progesterone receptor IVD, antibody
Device name
Estrogen Receptor Clone 6F11 Ready-To-Use Primary Antibody for BOND
Model / Ref / Catalog
PA0009
Primary DI / UDI-DI
05055331320421
Basic UDI-DI
B-05055331320421
FDA product code
MYA
EMDN code
W01030709 Primary antisera for immunohistology
GMDN term
Estrogen (oestrogen)/progesterone receptor IVD, antibody
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
864.1860
EU registration type
Legacy device (under a directive)
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under PRIMARY ANTISERA FOR IMMUNOHISTOLOGY.

Other devices from Leica Biosystems Newcastle, Limited

See all devices from Leica Biosystems Newcastle, Limited →

Properties

  • Contains animal tissues or cells
  • Reagent
  • Professional testing
  • Combination product
  • Lot / batch number
  • Expiration date
Other properties (19, all answered No)